欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号SE/H/2141/001
药品名称Axhidrox
活性成分
    • glycopyrronium bromide 2.2 mg/dose
剂型Cream
上市许可持有人Dr. August Wolff GmbH & Co. KG Arzneimittel, Germany
参考成员国 - 产品名称Sweden (SE)
互认成员国 - 产品名称
    • Greece (GR)
    • Finland (FI)
    • France (FR)
    • Latvia (LV)
    • Ireland (IE)
    • Lithuania (LT)
      -
    • Bulgaria (BG)
      Axhidrox
    • Estonia (EE)
    • Czechia (CZ)
      Axhidrox 2,2 mg/aktivace pumpy krém
    • Croatia (HR)
    • Hungary (HU)
      Axhidrox krém
    • Poland (PL)
    • Germany (DE)
      Sudormin 8 mg/g Creme / Axhidrox 8 mg/g Creme
    • Romania (RO)
      Axhidrox 2,2 mg/acționare cu pompă, cremă
    • Denmark (DK)
    • Slovenia (SI)
    • Netherlands (NL)
    • Belgium (BE)
    • Slovakia (SK)
    • Austria (AT)
    • Luxembourg (LU)
    • Norway (NO)
许可日期2022/03/10
最近更新日期2023/11/17
药物ATC编码
    • D11AA01 glycopyrronium
申请类型
  • TypeLevel1:Known Active Substance
  • TypeLevel2:Initial Application
  • TypeLevel3:Full Dossier Art 8.3(i) Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase